Tiziana Hongler is a member of Baker McKenzie's Intellectual Property & Technology practice group and Baker McKenzie's Healthcare and Life Sciences industry group.
After graduating from the University of Basel she has joined Baker McKenzie Zurich as a trainee lawyer and subsequently gained additional practical experience working in-house at Novartis Pharma AG for a period of six months.
Upon being admitted to the bar in 2022, she rejoined the Firm as an associate.
Professional Associations and Memberships
- Zurich Bar Association
- Switzerland (2022)
- University of Basel (Master of Law) (2018)
- Erasmus University Rotterdam (Summer School on Health Law and Ethics) (2016)
- University of Basel (Bachelor of Law) (2016)
Co-presenter, "EU-MDR vs.CH-MepV - Overcoming the EU/CH 'market access rift' in the post-MRA era," 18th annual Baker McKenzie Healthcare and Life Science Legal and Compliance Forum, November 2022
Co-author, "Switzerland: Software as a Medical Device," InsightPlus December 2022
Co-author, "Switzerland: The new Human Genetic Testings Act and Correlating Ordinances," InsightPlus November 2022,
Co-author, "Switzerland: Revision of Narcotics Act - Switzerland Fully Legalizes Medical Cannabis," InsightPlus September 2022
Co-author, "Switzerland: Price Disclosures in Consumer Transactions," InsightPlus, June 2022